Cargando…
Nilotinib for the Frontline Treatment of Chronic Myeloid Leukemia Carrying the p230 Transcript: Dream or Reality?
Autores principales: | Capuozzo, Maurizio, Ottaiano, Alessandro, Nava, Eduardo, Cascone, Stefania, Cinque, Claudia, Vercellone, Adriano, Scognamiglio, Corinne, Palumbo, Emilia, Iaffaioli, Rosario V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3910244/ https://www.ncbi.nlm.nih.gov/pubmed/24551597 http://dx.doi.org/10.3389/fonc.2014.00017 |
Ejemplares similares
-
Epidemiology and Economic Impact of Celiac Disease in the South Vesuvian Area of Naples: A Survey
por: Capuozzo, Maurizio, et al.
Publicado: (2013) -
Telaprevir or boceprevir for hepatitis C treatment: a first survey on pharmacoutilization
por: Capuozzo, Maurizio, et al.
Publicado: (2013) -
Assessment of expenditure control and prescriptive appropriateness of biological drugs in autoimmune diseases and chronic inflammatory bowel disease
por: Capuozzo, Maurizio, et al.
Publicado: (2013) -
Etanercept induces remission of polyarteritis nodosa: a case report
por: Capuozzo, Maurizio, et al.
Publicado: (2014) -
Early Complete Molecular Response to First-Line Nilotinib in Two Patients with Chronic Myeloid Leukemia Carrying the p230 Transcript
por: Greco, Marianna, et al.
Publicado: (2013)